Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Jean‐Pierre Routy

Biographic Data

ID8984737
NAMEJean‐Pierre Routy
GIVEN NAMESJean‐Pierre
FAMILY NAMERouty
SIGNATUREROUTY J P
AFFILIATIONSMcGill University Health Centre
ORCID0000-0001-9897-7589
VERIFIEDYes
TOTAL WORKS8
TOTAL CITATIONS0
WORKS AS AUTHOR8
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2010
LATEST PUBLICATION YEAR2024
H-INDEX0
  • Self-tests for Covid-19

    Open Access•Apoorva Anand, Fiorella Vialard et al.•ARTICLE•PLOS Global Public Health•2024

    COVID-19 self-testing strategy (COVIDST) can rapidly identify symptomatic and asymptomatic SARS-CoV-2-infected individuals and their contacts, potentially reducing transmission. In this living systematic review, we evaluated the evidence for real-world COVIDST performance. Two independent reviewers searched six databases (PubMed, Embase, Web of Science, World Health Organization database, Cochrane COVID-19 registry, Europe PMC) for the period Apr…

  • Sars-CoV-2 pre-exposure prophylaxis

    Open Access•Jing Ouyang, Silvère D Zaongo et al.•ARTICLE•Frontiers in Public Health•2022

    The unprecedented worldwide spread of SARS-CoV-2 has imposed severe challenges on global health care systems. The roll-out and widespread administration of COVID-19 vaccines has been deemed a major milestone in the race to restrict the severity of the infection. Vaccines have as yet not entirely suppressed the relentless progression of the pandemic, due mainly to the emergence of new virus variants, and also secondary to the waning of protective …

  • Characterization of people living with HIV in a Montreal-based tertiary care center with Covid-19 during the first wave of the pandemic

    Derek Fehr, Bertrand Lebouché et al.•ARTICLE•AIDS Care•2022

    [347, 726] and six had detectable plasma HIV viral loads. Median duration of HIV was 17 years [7, 22] and 30 individuals had been prescribed antiretroviral therapy. Five persons were asymptomatic. Of symptomatic persons, 21 (12%), 1 (4%) and 3 (12%) individuals had mild, moderate and severe disease, respectively. Three individuals died with COVID-19. In one case, the cause of death was due to COVID-19, whereas in the other two cases, the individu…

  • Multiplexed technologies for sexually transmitted infections

    Open Access•Faheel Naeem, Angela Karellis et al.•ARTICLE•BMJ Global Health•2021

    Introduction Conventional care packages around screening for sexually transmitted infections (STIs) entail multiple clinic visits and precipitate losses to follow-up. To prevent these losses, multiplexed technologies for STIs (immunochromatographic tests/devices/assays and molecular assays that can screen multiple pathogens or multiple strains of one STI) can yield same-day results in a single visit. Research evidence of patient-centred (preferen…

  • Primary lung cancer diagnoses in people living with HIV in a large clinical centre in Montreal, Canada over 3 decades

    Béatrice Bichara, Jean-Pierre Routy et al.•ARTICLE•AIDS Care•2020

    Lung cancer is the most frequent type of cancer-related death in people living with HIV (PLWH). We conducted a review of primary lung cancers in PLWH at the McGill University Health Centre from 1988–May 2018 to understand potential factors contributing to their development prior to the implementation of a lung cancer screening program. Twenty-seven individuals had a diagnosis of a lung tumor. Of these individuals, 21 (78%) had a primary lung canc…

  • Evaluation of a project to engage patients in the development of a patient‐reported measure for HIV care (the I‐Score Study)

    Open Access•David Lessard, Kay Engler et al.•ARTICLE•Health Expectations•2019

    BACKGROUND: Patient engagement (PE), patients' meaningful involvement in research through partnerships and sensitivity to their expertise, is receiving attention. However, PE initiatives are poorly reported and little is known about patients' perspective on PE. OBJECTIVE: To document and evaluate the first phase (22 months) of a PE Project for the I-Score Study which is developing a patient-reported measure of HIV treatment adherence barriers, we…

  • Minimal interference

    Bertrand Lebouché, Kay Engler et al.•ARTICLE•AIDS Care•2013

    Given international interest in "treatment as prevention" (TasP) and the pertinence of optimizing antiretroviral treatment (ART) regimens for TasP, 19 French HIV experts were interviewed on their criteria for ART if used specifically for prevention with HIV-positive persons. Through content analysis of the interview material, nine criteria were identified. The most endorsed criteria, collectively, suggest a choice of treatment based on "minimal i…

  • Altruism motivates participation in a therapeutic HIV vaccine trial (CTN 173)

    Louise Balfour, Kimberly Corace et al.•ARTICLE•AIDS Care•2010

    This is the first study examining motivation to participate in an HIV therapeutic vaccine trial of Remune and ALVAC. Trial participants (N=49) completed psychological measures at baseline. While 69% reported some personal risk in participating, 100% felt hopeful for societal benefits. Trial participants also reported high levels of existential well-being (e.g., "I believe there is some real purpose for my life"). Results suggest that HIV therapeu…

No prominent works on this page.

  • Altruism motivates participation in a therapeutic HIV vaccine trial (CTN 173)

    Louise Balfour, Kimberly Corace et al.•ARTICLE•AIDS Care•2010

    This is the first study examining motivation to participate in an HIV therapeutic vaccine trial of Remune and ALVAC. Trial participants (N=49) completed psychological measures at baseline. While 69% reported some personal risk in participating, 100% felt hopeful for societal benefits. Trial participants also reported high levels of existential well-being (e.g., "I believe there is some real purpose for my life"). Results suggest that HIV therapeu…

  • Minimal interference

    Bertrand Lebouché, Kay Engler et al.•ARTICLE•AIDS Care•2013

    Given international interest in "treatment as prevention" (TasP) and the pertinence of optimizing antiretroviral treatment (ART) regimens for TasP, 19 French HIV experts were interviewed on their criteria for ART if used specifically for prevention with HIV-positive persons. Through content analysis of the interview material, nine criteria were identified. The most endorsed criteria, collectively, suggest a choice of treatment based on "minimal i…

  • Evaluation of a project to engage patients in the development of a patient‐reported measure for HIV care (the I‐Score Study)

    Open Access•David Lessard, Kay Engler et al.•ARTICLE•Health Expectations•2019

    BACKGROUND: Patient engagement (PE), patients' meaningful involvement in research through partnerships and sensitivity to their expertise, is receiving attention. However, PE initiatives are poorly reported and little is known about patients' perspective on PE. OBJECTIVE: To document and evaluate the first phase (22 months) of a PE Project for the I-Score Study which is developing a patient-reported measure of HIV treatment adherence barriers, we…

  • Primary lung cancer diagnoses in people living with HIV in a large clinical centre in Montreal, Canada over 3 decades

    Béatrice Bichara, Jean-Pierre Routy et al.•ARTICLE•AIDS Care•2020

    Lung cancer is the most frequent type of cancer-related death in people living with HIV (PLWH). We conducted a review of primary lung cancers in PLWH at the McGill University Health Centre from 1988–May 2018 to understand potential factors contributing to their development prior to the implementation of a lung cancer screening program. Twenty-seven individuals had a diagnosis of a lung tumor. Of these individuals, 21 (78%) had a primary lung canc…

  • Multiplexed technologies for sexually transmitted infections

    Open Access•Faheel Naeem, Angela Karellis et al.•ARTICLE•BMJ Global Health•2021

    Introduction Conventional care packages around screening for sexually transmitted infections (STIs) entail multiple clinic visits and precipitate losses to follow-up. To prevent these losses, multiplexed technologies for STIs (immunochromatographic tests/devices/assays and molecular assays that can screen multiple pathogens or multiple strains of one STI) can yield same-day results in a single visit. Research evidence of patient-centred (preferen…

  • Sars-CoV-2 pre-exposure prophylaxis

    Open Access•Jing Ouyang, Silvère D Zaongo et al.•ARTICLE•Frontiers in Public Health•2022

    The unprecedented worldwide spread of SARS-CoV-2 has imposed severe challenges on global health care systems. The roll-out and widespread administration of COVID-19 vaccines has been deemed a major milestone in the race to restrict the severity of the infection. Vaccines have as yet not entirely suppressed the relentless progression of the pandemic, due mainly to the emergence of new virus variants, and also secondary to the waning of protective …

  • Characterization of people living with HIV in a Montreal-based tertiary care center with Covid-19 during the first wave of the pandemic

    Derek Fehr, Bertrand Lebouché et al.•ARTICLE•AIDS Care•2022

    [347, 726] and six had detectable plasma HIV viral loads. Median duration of HIV was 17 years [7, 22] and 30 individuals had been prescribed antiretroviral therapy. Five persons were asymptomatic. Of symptomatic persons, 21 (12%), 1 (4%) and 3 (12%) individuals had mild, moderate and severe disease, respectively. Three individuals died with COVID-19. In one case, the cause of death was due to COVID-19, whereas in the other two cases, the individu…

  • Self-tests for Covid-19

    Open Access•Apoorva Anand, Fiorella Vialard et al.•ARTICLE•PLOS Global Public Health•2024

    COVID-19 self-testing strategy (COVIDST) can rapidly identify symptomatic and asymptomatic SARS-CoV-2-infected individuals and their contacts, potentially reducing transmission. In this living systematic review, we evaluated the evidence for real-world COVIDST performance. Two independent reviewers searched six databases (PubMed, Embase, Web of Science, World Health Organization database, Cochrane COVID-19 registry, Europe PMC) for the period Apr…

Medicine (8 works) · Family medicine (5 works) · Internal Medicine (5 works) · Psychology (4 works) · HIV/AIDS Research and Interventions (3 works) · Biology (2 works) · COVID-19 Clinical Research Studies (2 works) · Disease (2 works) · Environmental health (2 works) · Immunology (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae